# Study to Evaluate Drug Levels of Various Solid Gastro-retentive Formulations of Deucravacitinib (BMS-986165) in Healthy Participants

> **NCT06566768** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 52 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** Deucravacitinib

## Key facts

- **NCT ID:** NCT06566768
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-07
- **Primary completion:** 2025-06-13
- **Final completion:** 2025-06-13
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2025-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06566768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06566768, "Study to Evaluate Drug Levels of Various Solid Gastro-retentive Formulations of Deucravacitinib (BMS-986165) in Healthy Participants". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06566768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*